Number of the records: 1  

Anti-proliferative activity of a novel tricyclic triterpenoid acid from Commiphora africana resin against four human cancer cell lines

  1. 1.
    SYSNO ASEP0523785
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleAnti-proliferative activity of a novel tricyclic triterpenoid acid from Commiphora africana resin against four human cancer cell lines
    Author(s) Dinku, W. (ET)
    Isaksson, J. (NO)
    Rylandsholm, F. G. (NO)
    Bouř, Petr (UOCHB-X) RID, ORCID
    Brichtová, Eva (UOCHB-X) ORCID
    Choi, S. U. (KR)
    Lee, S. H. (KR)
    Jung, Y. S. (KR)
    No, Z. S. (ET)
    Svendsen, J. S. M. (NO)
    Aasen, A. J. (NO)
    Dekebo, A. (ET)
    Article number16
    Source TitleApplied Biological Chemistry. - : Springer - ISSN 2468-0834
    Roč. 63, č. 1 (2020)
    Number of pages11 s.
    Languageeng - English
    CountrySG - Singapore
    KeywordsCommiphora africana ; Commafric A ; anti-proliferative ; SRB ; A549 cell line
    Subject RIVBO - Biophysics
    OECD categoryBiophysics
    R&D ProjectsGA18-05770S GA ČR - Czech Science Foundation (CSF)
    LTC17012 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF16_019/0000729 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUOCHB-X - RVO:61388963
    UT WOS000520375700001
    EID SCOPUS85081992655
    DOI10.1186/s13765-020-00499-w
    AnnotationMyrrh, a resin derived from the damaged bark of Commiphora genus, has traditionally been used for treatment of various human diseases, such as amenorrhea, ache, tumors, fever, and stomach pains. In spite of this widespread use of the myrrh in Ethiopia, the pharmacological activity and chemical composition have not been studied in detail. A new tricyclic triterpene acid (3S,4S,14S,7E,17E,21Z)-3,30-dihydroxypodioda-7,17,21-trien-4-carboxylic acid (commafric A) has been isolated from a crude methanolic extract of Commiphora africana (A. Rich.) Engl. resin along with the known pentacyclic triterpene alpha-amyrin. The structure of commafric A was characterized using different spectroscopic techniques such as 1D and 2D NMR, IR, and VCD combined with computations. The anti-proliferative activity of both isolated compounds was evaluated using SRB based colorimetric cellular assay against four human cancer cell lines. Etoposide was used as a positive control. Commafric A showed significant anti-proliferative effects against non-small cell lung cancer (A549) with IC50 values of 4.52 mu g/ml. The pentacyclic triterpene alpha-amyrin showed a weak anti-proliferative activity against A2780 (ovarian cancer), MIA-PaCa-2 (pancreatic cancer), and SNU638 (stomach cancer) cell lines tested with IC50 values ranging 9.28 to 28.22 mu g/ml. Commafric A possessed anti-proliferative activity against non-small cell lung cancer (A549), which suggests that commafric A has potential to be further optimized being a lead compound in the search for new drugs against cancer diseases.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2021
    Electronic addresshttps://applbiolchem.springeropen.com/articles/10.1186/s13765-020-00499-w
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.